○Eita Sasaki1, Hideki Asanuma2, Haruka Momose3, Keiko Furuhata3, Takuo Mizukami3, Takayuki Matsumura1, Isao Hamaguchi3, Yoshimasa Takahashi1
(1.Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan, 2.Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases, Tokyo, Japan, 3.Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan)
Abstract password authentication.
Please enter password to access the abstracts.
The Secretariat will inform registered participants by e-mail on August 28. <tentative>